NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/06/2023
Back to search
Official data from USPTO
CUVRIOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
06/06/2023
Trademark type
Combined
Nice classes
5
Filing date
10/05/2021
Registration date
06/06/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/06/2023
Last transaction
06/06/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/28/2023
First use in commerce
03/28/2023
Drawing code
3
Owner type
99
Owner location
Paris, FR
Examiner
DETMER, CAROLYN
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "CUVRIOR" in blue, with a swirling brown and gold ribbon appearing above it.
Holders and representatives
Holders
ORPHALAN
Representatives
Heather Smith-Carra BANNER & WITCOFF, LTD.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of Wilson's disease; Pharmaceutical products for the treatment of Wilson's disease; Chemical preparations for medical purposesfor treatment of Wilson's disease; Chemical preparations for pharmaceutical purposesfor treatment of Wilson's disease; Medicine for the treatment of Wilson's disease; Medicinal substancestherapeutic medication for the treatment of Wilson's disease; Medicinal preparations for the treatment of Wilson's disease; chemical preparations for medical or pharmaceutical use for the treatment of Wilson's disease; pharmaceutical products and medicines for the treatment of Wilson's disease
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/06/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/06/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/05/2023
DOCK
ASSIGNED TO EXAMINER
05/04/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/27/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/27/2023
IUAF
USE AMENDMENT FILED
04/07/2023
EISU
TEAS STATEMENT OF USE RECEIVED
04/07/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/18/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/23/2022
PUBO
PUBLISHED FOR OPPOSITION
08/23/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/21/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/11/2022
GNRT
NON-FINAL ACTION E-MAILED
07/11/2022
CNRT
NON-FINAL ACTION WRITTEN
07/11/2022
DOCK
ASSIGNED TO EXAMINER
07/08/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/30/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/29/2021
NWAP
NEW APPLICATION ENTERED
10/08/2021
Continuous trademark protection
Get notified about every new filing that threatens CUVRIOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.